These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids. Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056 [TBL] [Abstract][Full Text] [Related]
28. Prostaglandin I2 (prostacyclin) formation in lung tissues of Swiss mice. Hokama Y; Matsuo M; Seto DS Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):145-8. PubMed ID: 6359307 [TBL] [Abstract][Full Text] [Related]
29. Chemical and enzymic conversions of the prostaglandin endoperoxide PGH2. Nugteren DH; Christ-Hazelhof E Adv Prostaglandin Thromboxane Res; 1980; 6():129-37. PubMed ID: 7386254 [No Abstract] [Full Text] [Related]
30. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Salmon JA; Smith DR; Flower RJ; Moncada S; Vane JR Biochim Biophys Acta; 1978 Mar; 523(1):250-62. PubMed ID: 415760 [TBL] [Abstract][Full Text] [Related]
31. The action of cyclooxygenase and prostacyclin-synthetase inhibitors on platelet-vessel wall interaction. Bourgain RH; Six F; Andries R Artery; 1980; 8(1):96-100. PubMed ID: 6775620 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Marnett LJ; Siedlik PH; Ochs RC; Pagels WR; Das M; Honn KV; Warnock RH; Tainer BE; Eling TE Mol Pharmacol; 1984 Sep; 26(2):328-35. PubMed ID: 6434940 [TBL] [Abstract][Full Text] [Related]
33. Relevance of vascular PGI2 synthase to vascular prostacyclin production in Dahl rats susceptible to salt-induced hypertension. Uehara Y; Ishimitsu T; Iwai J; Ishii M; Sugimoto T Am J Hypertens; 1990 Apr; 3(4):313-6. PubMed ID: 2112004 [TBL] [Abstract][Full Text] [Related]
34. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase. Weksler BB J Cell Physiol; 1990 Mar; 142(3):514-22. PubMed ID: 2107185 [TBL] [Abstract][Full Text] [Related]
35. Cellular distribution of prostacyclin synthase and specific prostacyclin binding sites in bovine corpora lutea of pregnancy. Chegini N; Lei ZM; Rao CV Mol Cell Endocrinol; 1990 Jun; 71(2):133-40. PubMed ID: 2115851 [TBL] [Abstract][Full Text] [Related]
36. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Ruan KH; Deng H; So SP Biochemistry; 2006 Nov; 45(47):14003-11. PubMed ID: 17115695 [TBL] [Abstract][Full Text] [Related]
37. Inactivation of vascular prostacyclin synthetase by platelet lipoxygenase products. Turk J; Wyche A; Needleman P Biochem Biophys Res Commun; 1980 Aug; 95(4):1628-34. PubMed ID: 6774728 [No Abstract] [Full Text] [Related]
38. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. Bachschmid M; Thurau S; Zou MH; Ullrich V FASEB J; 2003 May; 17(8):914-6. PubMed ID: 12670882 [TBL] [Abstract][Full Text] [Related]
39. Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. Merhi-Soussi F; Dominguez Z; Macovschi O; Dubois M; Savany A; Lagarde M; Prigent AF J Leukoc Biol; 2000 Dec; 68(6):881-9. PubMed ID: 11129656 [TBL] [Abstract][Full Text] [Related]